Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, J. H.
Right arrow Articles by Tauchi, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, J. H.
Right arrow Articles by Tauchi, P.
Related Collections
Right arrow Sentinel lymph node

Annals of Surgical Oncology, Vol 7, Issue 6 450-455, Copyright © 2000 by Society of Surgical Oncology

ARTICLES

Sentinel node staging for cutaneous melanoma in a university-affiliated community care setting

J. H. Wong, S. Steinemann, C. Yonehara, M. N. Coel, P. J. Ko, K. Tonaki and P. Tauchi
Department of Surgery, University of Hawaii School of Medicine, Honolulu 96813, USA.

BACKGROUND: The feasibility of intraoperative lymphatic mapping and sentinel lymphadenectomy (SLND) in settings other than high-volume specialized clinics has been questioned. We sought to determine the feasibility of SLND in a university-affiliated private teaching hospital. METHODS: A multidisciplinary sentinel node program was established to include surgeons, nuclear medicine physicians, and pathologists. Within this program, 79 patients with cutaneous melanoma underwent attempted SLND after cutaneous lymphoscintigraphy (CL), between January 1994 and December 1998. All sentinel nodes were examined by hematoxylin-eosin staining and determined whether negative for evidence metastatic disease by both S-100 and HMB 45 immunohistochemical staining. RESULTS: CL was successful in 77 (97%) of 79 patients. A total of 88 lymphatic basins were found to be at risk for metastatic disease by CL. SLND was not successful in the two patients who did not have a successful CL. Sentinel nodes were identified in all but three patients with the remaining 88 lymphatic basins (technical success, 97%). There was one false negative in this group of patients (approximately 1%). CONCLUSIONS: SLND is a highly accurate way of staging the regional node basin. Our technical success rates and false-negative rates indicate the feasibility of this approach in settings other than high-volume specialty clinics.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
R. S. Krouse, R. E. Schwarz, and S. P. L. Leong
Blue Dye for Sentinel Lymph Node Mapping: Not Too Sensitive, but Too Hypersensitive?
Ann. Surg. Oncol., April 1, 2001; 8(3): 268 - 269.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society of Surgical Oncology.